title: Haemostatic factors and inhibitors and coronary artery bypass grafting: preoperative alterations and relations to graft occlusion.
abstract: Graft closure remains a major problem after coronary artery bypass surgery. While a number of graft characteristics influencing the risk of occlusion have been defined, the role of haemostatic factors and inhibitors has not been studied in detail. The present study examined the time course of changes in blood coagulation and fibrinolytic function after coronary artery bypass grafting in 20 consecutive patients. Pre- and postoperative determinations of haemostatic factors and inhibitors were also related to the presence of graft occlusion assessed by angiography at three months after surgery. A broad panel of haemostatic tests was used preoperatively, on the first, third and eight postoperative days, and at three months after surgery. A particular emphasis was placed on fibrinogen, factor VII activity, von Willebrand factor (vWF), plasminogen activator inhibitor-1 (PAI-1) activity, anticoagulant proteins C and S, thrombin-antithrombin complex and D-dimer. A marked activation of the coagulation cascade was noted postoperatively along with enhanced degradation of cross-linked fibrin. The degree of activation of blood coagulation and fibrinolysis differed widely between individuals and appeared to relate only partly to the acute phase reaction produced by the surgical trauma. Preoperative values of haemostatic factors and inhibitors showed fairly weak associations with the levels of postoperative determinations.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Cardiology, Karolinska Hospital, Stockholm, Sweden.
authors.forename: E
authors.initials: E
authors.lastname: Moor
authors.forename: A
authors.initials: A
authors.lastname: Hamsten
authors.forename: M
authors.initials: M
authors.lastname: Blombäck
authors.forename: I
authors.initials: I
authors.lastname: Herzfeld
authors.forename: B
authors.initials: B
authors.lastname: Wiman
authors.forename: L
authors.initials: L
authors.lastname: Rydén
mesh_terms: D000209:Acute-Phase Proteins / Q000032:analysis; D000368:Aged; D001241:Aspirin / Q000627:therapeutic use; D001777:Blood Coagulation; D001779:Blood Coagulation Factors / Q000037:antagonists & inhibitors / Q000502:physiology*; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000097:blood* / Q000188:drug therapy / Q000601:surgery*; D004198:Disease Susceptibility / Q000097:blood; D005342:Fibrinolysis; D006083:Graft Occlusion, Vascular / Q000097:blood / Q000209:etiology*; D006487:Hemostasis; D006801:Humans; D007387:Internal Mammary-Coronary Artery Anastomosis; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D011184:Postoperative Period; D012501:Saphenous Vein / Q000601:surgery
chemical_list: D000209:Acute-Phase Proteins; D001779:Blood Coagulation Factors; D001241:Aspirin